Kanamycin API is a pharmaceutical-grade aminoglycoside antibiotic used for the treatment of serious bacterial infections caused by susceptible Gram-negative and selected Gram-positive microorganisms. It acts by binding irreversibly to the 30S ribosomal subunit, disrupting bacterial protein synthesis and leading to rapid bacterial cell death.
Kanamycin is indicated for severe infections including septicemia, respiratory tract infections, urinary tract infections, intra-abdominal infections, bone and joint infections, and is also used as a second-line agent in multidrug-resistant tuberculosis (MDR-TB) treatment protocols in specific clinical settings.
Manufactured under WHO-GMP-certified facilities, our Kanamycin API is produced using advanced pharmaceutical manufacturing technologies to ensure exceptional purity, potency, stability, and batch-to-batch consistency. Every batch undergoes rigorous quality testing and is supplied with Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), Technical Data Sheet (TDS), and complete regulatory documentation.
Kanamycin API is used in pharmaceutical formulations for treating severe bacterial infections and as a second-line treatment option for multidrug-resistant tuberculosis (MDR-TB).
Kanamycin binds to the bacterial 30S ribosomal subunit, inhibiting protein synthesis and causing bacterial cell death.
Yes. We provide CoA, MSDS, Technical Data Sheet (TDS), Product Specifications, and complete regulatory documentation with every shipment.
Yes. We supply Kanamycin API in commercial quantities with worldwide export support and customized packaging.
Get Bulk Quote via WhatsApp